International Union Against Tuberculosis and Lung Disease
- World rank, all time
- #35,927 of 42,892
- Rank in United States
- #7,588 of 8,685
- Research works
- 125 ▼ 24% vs 2013–17
- Citations
- 2.3k 18.6 per fractional work
- Top-10% rate
- 6.5% record average 16.5%
- Open access
- 62% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 5.2×
- Nursing 4.3×
- Health Professions 3.8×
- Economics, Econometrics and Finance 3.3×
- Immunology and Microbiology 2.6×
- Medicine 2.5×
- Environmental Science 2.4×
- Business, Management and Accounting 1.0×
- Psychology 1.0×
- Decision Sciences 0.8×
- Neuroscience 0.5×
- Agricultural and Biological Sciences 0.4×
- Arts and Humanities 0.3×
- Social Sciences 0.3×
- Materials Science 0.2×
- Biochemistry, Genetics and Molecular Biology 0.1×
Who are the top researchers at International Union Against Tuberculosis and Lung Disease?
Ranked on the composite score, K Stýblo, Rafael de Lorenzo García and Pranay Lal lead among researchers whose main affiliation is International Union Against Tuberculosis and Lung Disease.
- 1 K Stýblo United States · #146,524 worldwide 61 citations · 29 works
- 2 Rafael de Lorenzo García United States · #394,002 worldwide 6 citations · 27 works
- 3 Pranay Lal United States · #1,436,337 worldwide 22 citations · 17 works
Which keywords describe research at International Union Against Tuberculosis and Lung Disease?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Treatment, Diagnosis, Vaccine, Drug Resistance, Immune Response, Mycobacterium tuberculosis and Tuberculosis.
- Universal Coverage
- Health Education
- Spinal Epidural Abscess
- Community-Acquired Pneumonia
- Pneumocystis
- Opportunistic Infections
- Global Trade
- Ethical Considerations
- Surgical Management
- Antimicrobial Resistance
- Abdominal Tuberculosis
- HIV Infection
- Smoking Cessation
- Psychiatric Disorders
- Non-Communicable Diseases
- Public Health
- Tuberculosis
- Immune Response
- Vaccine
- Treatment
- Epidemiology
- Diagnosis
- Drug Resistance
- Mycobacterium tuberculosis
- Antiretroviral Therapy
- Clinical Practice Guidelines
- Respiratory Infections
- Cancer Risk
- Tobacco Use
- HIV
- Diagnostic Challenges
- Health System Reform
- Antibiotic Resistance
- Corporate Political Activity
- Immunocompromised Patients
- Low- and Middle-Income Countries
- Pneumonia
- Pneumococcal Conjugate Vaccine
- Tuberculous Meningitis
- Health Financing
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology40▲ 7.9×36 topics
- Treatment32▲ 20×9 topics
- Diagnosis31▲ 24×8 topics
- Vaccine26▲ 52×6 topics
- Drug Resistance25▲ 63×4 topics
- Immune Response25▲ 32×7 topics
- Mycobacterium tuberculosis24▲ 285×1 topic
- Tuberculosis24▲ 343×1 topic
- Antiretroviral Therapy10▲ 35×6 topics
- Public Health7▲ 4.1×20 topics
- Clinical Practice Guidelines7▲ 9.7×4 topics
- Non-Communicable Diseases6▲ 31×4 topics
- Respiratory Infections5▲ 42×3 topics
- Psychiatric Disorders5▲ 25×2 topics
- Cancer Risk4▲ 14×2 topics
- Smoking Cessation4▲ 103×1 topic
- Tobacco Use4▲ 103×1 topic
- HIV Infection4▲ 27×3 topics
- HIV4▲ 27×4 topics
- Abdominal Tuberculosis4▲ 144×1 topic
- Diagnostic Challenges4▲ 144×1 topic
- Antimicrobial Resistance4▲ 11×5 topics
- Health System Reform4▲ 39×2 topics
- Surgical Management4▲ 6.4×3 topics
- Antibiotic Resistance4▲ 6.9×3 topics
- Ethical Considerations4▲ 8.6×3 topics
- Corporate Political Activity3▲ 92×1 topic
- Global Trade3▲ 19×1 topic
- Immunocompromised Patients3▲ 40×2 topics
- Opportunistic Infections3▲ 70×2 topics
- Low- and Middle-Income Countries3▲ 58×2 topics
- Pneumocystis3▲ 92×1 topic
- Pneumonia3▲ 41×1 topic
- Community-Acquired Pneumonia3▲ 63×1 topic
- Pneumococcal Conjugate Vaccine3▲ 63×1 topic
- Spinal Epidural Abscess3▲ 77×1 topic
- Tuberculous Meningitis3▲ 77×1 topic
- Health Education3▲ 11×5 topics
- Health Financing3▲ 96×1 topic
- Universal Coverage3▲ 96×1 topic
Which research topics does International Union Against Tuberculosis and Lung Disease publish most on?
By volume in 2022–2025: Tuberculosis Research and Epidemiology, Energy and Environment Impacts, Diverse Scientific Research Studies and Public Health and Nutrition.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Tuberculosis Research and Epidemiology Infectious Diseases 2 works
- 2 Energy and Environment Impacts Pollution 1 works
- 3 Diverse Scientific Research Studies General Health Professions 1 works
- 4 Public Health and Nutrition Pediatrics, Perinatology and Child Health 0 works
- 5 Smoking Behavior and Cessation Physiology 0 works
- 6 Global Public Health Policies and Epidemiology Organizational Behavior and Human Resource Management 0 works
- 7 Diagnosis and treatment of tuberculosis Surgery 0 works
- 8 Global Health and Surgery Public Health, Environmental and Occupational Health 0 works
- 9 Migration, Health and Trauma Clinical Psychology 0 works
- 10 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has International Union Against Tuberculosis and Lung Disease's research output changed?
Output in 2018–2022 was 24% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.